Project Pharma

Project Farma is a life sciences consulting and services company focused on biomanufacturing strategy, technical operations, and facility execution for biopharma and advanced therapy developers. The company supports clients across the manufacturing lifecycle, including due diligence, capital project delivery, facility builds, tech transfer, commissioning, qualification and validation, automation, quality and regulatory support, supply chain, and operational readiness. Project Farma is especially well known for work in complex biologics and advanced modalities such as cell therapy, gene therapy, mRNA, and radioligand programs. It operates as part of Precision for Medicine following its acquisition by Precision Medicine Group in January 2021. Rather than developing its own therapeutic pipeline, it provides specialized infrastructure and operational expertise that helps clients move products from early development through commercial manufacturing.